Changes in neuropeptide‐containing nerves in human colonic mucosa with inflammatory bowel disease

Pathology International

Volumn 44, Issue 8, 1994, Pages 624-634

  Kimura, Mitsuo ^a   Masuda, Takayuki ^a   Hiwatashi, Nobuo ^a   Toyota, Takayoshi ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Crohn's disease; inflammatory bowel disease; substance P; ulcerative colitis; vasoactive intestinal polypeptide

Indexed keywords

CORTICOSTEROID; NEUROPEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0027978626     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1994.tb01723.x     Document Type: Article

References (42)

1. Neuropeptide regulation of mucosal immune system
2. Specific binding sites for vasoactive intestinal polypeptide on non‐adherent peripheral blood lymphocytes
3. Human intraepithelial lymphocytes: Immunomodulation and receptor binding of vasoactive intestinal peptide
4. Substance P recognition by a subset of human T lymphocytes
5. Effects of high in vivo levels of vasoactive intestinal polypeptide on function of circulating lymphocytes in humans
6. Luck GD. Gastrointestinal neuropeptides suppress human colonic lamina propria lymphocytes DNA synthesis
7. Modulating effect of beta‐endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferation response of peripheral blood T lymphocytes of nickel‐allergic patients to nickel sulfate
8. Specific stimulation of human T lymphocytes by substance P
9. Effect of neuropeptides present in skin on the proliferation of human peripheral blood monoclear cells and T cells
10. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells
11. Substance P enhances interferon‐gamma production by human blood mononuclear cells
12. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
13. Characterization of neuropeptide‐induced histamine release from human dispersed skin mast cells
14. Role of lymphocyte activation by substance P in rheumatoid arthritis
15. The effects of vasoactive intestinal peptide on human natural killer cell function
16. The immunology of inflammatory bowel disease
17. Immunohistochemical characterization, distribution, and ultrastructure of lymphocytes bearing T‐cell receptor gamma/delta in inflammatory bowel disease
18. Tissue localization and relative distribution of regulatory peptides in separated layer from the human bowel
19. Regional difference in concentration of regulatory peptides in human colon mucosal biopsy
20. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation
21. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease
22. Peptide‐containing nerve fibers in the gut wall in Crohn's disease
23. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases
24. Topical treatment of ulcerative proctitis with lidocaine
25. Abnormalities of vasoactive intestinal polypeptide‐containing nerves in Crohn's disease
26. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease
27. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease
28. Pathology of idiopathic inflammatory bowel disease
29. Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunocytochemically in subjects with and without ulcerative colitis
30. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
31. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease
32. Identity of Leu‐19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
33. Immunohistochemical analysis of neural cell adhesion molecules: Differential expression in small round cell tumors of childhood and adolescence
34. Simultaneous localization of multiple antigens using the peroxidase‐labeled antibody method: A study on pituitary glands of the rat
35. HLADR expression on M cells overlying Peyer's patches is a common feature of human small intestine
36. Psychosocial aspects of ulcerative colitis and Crohn's disease
37. Neuroimmunomodulation in the intestinal mucosa
38. Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons
39. Light and electron microscopic immunolocalization of endothelial leukocyte adhesion molecule‐1 in inflammatory bowel disease. orphological evidence of active synthesis and secretion into vascular lumen
40. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells
41. Substance P induces the expression of the endothelial‐leukocyte adhesion molecule by microvascular endothelium
42. Glycoconjugate with Ulex europaeus agglutinin‐l‐binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel